GlycoNex Incorporation (TPEX:4168)
Taiwan · Delayed Price · Currency is TWD 24.30
+0.85 (3.62%)
Mar 24, 2026, 1:30 PM CST
GlycoNex Incorporation Revenue
In the year 2025, GlycoNex Incorporation had annual revenue of 37.86M TWD with 157.54% growth. GlycoNex Incorporation had revenue of 4.41M in the quarter ending December 31, 2025, with 38.61% growth.
Revenue
37.86M
Revenue Growth
+157.54%
P/S Ratio
67.02
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 37.86M | 23.16M | 157.54% |
| Dec 31, 2024 | 14.70M | 12.16M | 478.32% |
| Dec 31, 2023 | 2.54M | -27.54M | -91.55% |
| Dec 31, 2022 | 30.09M | 24.61M | 449.50% |
| Dec 31, 2021 | 5.48M | 5.02M | 1,113.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.14B |
| Apex Biotechnology | 1.94B |
| Synbio Tech | 1.04B |
| Chunghwa Chemical Synthesis & Biotech | 977.79M |
| 3D Global Biotech | 324.87M |
| G&E Herbal Biotechnology | 309.13M |
| HeXun Biosciences | 290.83M |
| Gwo Xi Stem Cell Applied Technology Co. , | 184.91M |